Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus

Abstract

Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis. Increasing arterial stiffness is closely associated with atherosclerotic cardiovascular diseases, and pulse wave velocity (PWV) is considered to be an indicator of arterial stiffness. The objective of this study was to identify the relationship between brachial-ankle pulse wave velocity (baPWV) and cardiovascular risk factors in patients with SLE. Age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBS), plasma lipid profile, plasma homocysteine, thiobarbituric acid reactive substances (TBARS), baPWV, ankle-brachial index (ABI), and SLE-related factors were determined in a total of 83 SLE patients (12 males and 71 females). All SLE patients were further classified into two subgroups according to baPWV value (baPWV 1400 cm/s, n 37 versus baPWV 1400 cm/s, n 46). The mean baPWV value of studied SLE patients was 1520 381 cm/s. Age, BMI, SBP, DBP, FBS, TBARS and homocysteine levels were significantly higher in SLE patients with baPWV value 1400 cm/s than in SLE patients with baPWV value 1400 cm/s. In addition, baPWV correlated significantly with age, SBP, DBP, FBS and homocysteine. Moreover, stepwise multiple regression analysis showed that age and SBP were independently associated with baPWV. The results of this study indicate a possible link between vascular stiffness measured by baPWV and cardiovascular risk factors in patients with SLE.

Keywords

arterial stiffness atherosclerosis brachial-ankle pulse wave velocity homocysteine systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Steinberg AD , Klinman DM. Pathogenesis of systemic lupus erythematosus . Rheum Dis Clin N Am 1988; 14: 25-41 .

Abu-Shakra M , Urowitz MB , Gladman DD , Gough J. Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death . J Rheumatol 1995; 22: 1259-1264 .

Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus . Arthritis Rheum 1999; 42: 338-346 .

Laurent S , Boutouyrie P , Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients . Hypertension 2001; 37: 1236-1241 .

Brodszki J , Bengtsson C , Lanne T , Nived O , Sturfelt G , Marsal K. Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus . Lupus 2004; 13: 917-923 .

Meaume S , Benetos A , Henry OF , Rudnichi A , Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects 70 years of age . Arterioscler Thromb Vasc Biol 2001; 21: 2046-2050 .

Toto-Moukouo JJ , Achimastos A , Asmar RG , Hugues CJ , Safar ME. Pulse wave velocity in patients with obesity and hypertension . Am Heart J 1986; 112: 136-140 .

Muramatsu J , Kobayashi A , Hasegawa N , Yokouchi S. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin . Atherosclerosis 1997; 130: 179-182 .

Airaksinen KE , Salmela PI , Linnaluoto MK , Ikaheimo MJ , Ahola K , Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen . Cardiovasc Res 1993; 27: 942-945 .

10.

Blacher J , Asmar R , Djane S , London GM , Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients . Hypertension 1999; 33: 1111-1117 .

11.

Yamashina A , Tomiyama H , Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement . Hypertens Res 2002; 25: 359-364 .

12.

Aso K , Miyata M , Kubo T et al. Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients . Hypertens Res 2003; 26: 807-813 .

13.

Yokoyama H , Hirasawa K , Aoki T , Ishiyama M , Koyama K. Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy . Diabet Med 2003; 20: 942-945 .

14.

Choi KM , Lee KW , Seo JA et al. Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome . Diabetes Res Clin Pract 2004; 66: 57-61 .

15.

Ohnishi H , Saitoh S , Takagi S et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: The Tanno and Sobetsu Study . Diabetes Care 2003; 26: 437-440 .

16.

Munakata M , Ito N , Nunokawa T , Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients . Am J Hypertens 2003; 16: 653-657 .

17.

Imanishi R , Seto S , Toda G et al. High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men . Hypertens Res 2004; 27: 71-78 .

18.

Selzer F , Sutton-Tyrrell K , Fitzgerald S , Tracy R , Kuller L , Manzi S. Vascular stiffness in women with systemic lupus erythematosus . Hypertension 2001; 37: 1075-1082 .

19.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

20.

Yamashina A , Tomiyama H , Arai T et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk . Hypertens Res 2003; 26: 615-622 .

21.

Friedewald WT , Levy RI , Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge . Clin Chem 1972; 18: 499-502 .

22.

Oteiza PI , Olin KL , Fraga CG , Keen CL. Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes . J Nutr 1995; 125: 823-829 .

23.

Bombardier C , Gladman DD , Urowitz MB et al. Derivation of the SLEDAI: a disease activity index for lupus patients . Arthritis Rheum 1992; 35: 630-640 .

24.

Chang DM , Lan JL , Lin HY , Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus . Arthritis Rheum 2002; 46: 2924-2927 .

25.

Tso TK , Huang HY , Chang CK , Liao YJ , Huang WN. Clinical evaluation of insulin resistance and -cell function by the homeostasis model assessment in patients with systemic lupus erythematosus . Clin Rheumatol 2004; 23: 416-420 .

26.

Sacks D , Bakal C , Beatty P et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease . J Vasc Interv Radiol 2002; 13: 353-353 .

27.

Theodoridou A , Bento L , D’Cruz DP , Khamashta MA , Hughes GRV. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study . Ann Rheum Dis 2003; 62: 1199-1203 .

28.

Newman AB , Siscovick DS , Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group . Circulation 1993; 88: 837-845 .

29.

van Popele NM , Grobbee DE , Bots ML et al. Association between arterial stiffness and atherosclerosis: The Rotterdam Study . Stroke 2001; 32: 454-460 .

30.

Tomiyama H , Yamashina A , Arai T et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects . Atherosclerosis 2003; 166: 303-309 .

31.

Manzi S , Meilahn EN , Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study . Am J Epidemiol 1997; 145: 408-415 .

32.

Petri M , Perez-Gutthann S , Spence D , Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus . Am J Med 1992; 93: 513-519 .

33.

Roman MJ , Shanker B , Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus . N Engl J Med 2003; 349: 2399-2406 .

34.

Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis . Am J Cardiol 1993; 71: 26B-31B .

35.

Tso TK , Huang WN , Huang HY , Liao YJ. Effect of anticardiolipin antibody on lipoprotein oxidation and antioxidant enzyme activities in normalipidaemic patients with systemic lupus erythematosus . Ann Rheum Dis 2004; 63 (Suppl I): 218-218 (abstract THU0368).

36.

Tso TK , Huang WN , Huang HY , Liao YJ. Oxidative status and antioxidant enzyme activities in patients with systemic lupus erythematosus . Ann Rheum Dis 2004; 63 (Suppl I): 218-218 (abstract THU0369).

37.

Clarke R , Daly L , Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease . N Engl J Med 1991; 324: 1149-1155 .

38.

Ueland PM , Refsum H , Beresford SAA , Vollset SE. The controversy over homocysteine and cardiovascular risk . Am J Clin Nutr 2000; 72: 324-332 .

39.

Welch GN , Loscalzo JN. Homocysteine and atherothrombosis . N Engl J Med 1998; 338: 1042-1050 .

40.

Hsu TS , Hsu LA , Chang CJ et al. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study . Thromb Res 2001; 102: 387-395 .

41.

Boushey CJ , Beresford SAA , Omenn GS , Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, probable benefits of increasing folic acid intakes . J Am Med Assoc 1995; 274: 1049-1057 .

42.

den Heijer M , Koster T , Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis . N Engl J Med 1996; 334: 759-762 .

43.

Refai TMK , Al-Salem IH , Nkansa-Dwamena D , Al-Salem MH. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients . Clin Rheumatol 2002; 21: 457-461 .

44.

Petri M , Roubenoff R , Dallal GE et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus . Lancet 1996; 348: 1120-1124 .

45.

Fijnheer R , Roest M , Haas FJ et al. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study . J Rheumatol 1998; 25: 1737-1742 .

46.

Huang WN , Tso TK , Huang HY , Liao YJ. Association of homocysteine with PWV in patients with systemic lupus erythematosus . Ann Rheum Dis 2004; 63 (Suppl I): 218-218 (abstract THU0370).

47.

Hossain GS , van Thienen JV , Werstuck GH et al. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia . J Biol Chem 2003; 278: 30317-30327 .

48.

Zhang C , Cai Y , Adachi MT et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response . J Biol Chem 2001; 276: 35867-35874 .

49.

Buemi M , Marino D , Di Pasquale G et al. Effects of homocysteine on proliferation, necrosis and apoptosis of vascular smooth muscle cells in culture and influence of folic acid . Thromb Res 2001; 104: 207-213 .